These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 8030628)

  • 41. Alzheimer's disease after remote head injury: an incidence study.
    Schofield PW; Tang M; Marder K; Bell K; Dooneief G; Chun M; Sano M; Stern Y; Mayeux R
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):119-24. PubMed ID: 9048710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
    Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Menstrual and reproductive factors and fracture risk: the Leisure World Cohort Study.
    Paganini-Hill A; Atchison KA; Gornbein JA; Nattiv A; Service SK; White SC
    J Womens Health (Larchmt); 2005 Nov; 14(9):808-19. PubMed ID: 16313208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Can variability in the hormonal status of elderly women assist in the decision to administer estrogens?
    Kuchel GA; Tannenbaum C; Greenspan SL; Resnick NM
    J Womens Health Gend Based Med; 2001 Mar; 10(2):109-16. PubMed ID: 11268296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of Alzheimer's disease in women.
    Michel JP
    Aging (Milano); 1998 Apr; 10(2):155-6. PubMed ID: 9666208
    [No Abstract]   [Full Text] [Related]  

  • 47. Post-menopausal estrogen deprivation and Alzheimer's disease.
    Gandy S; Duff K
    Exp Gerontol; 2000 Jul; 35(4):503-11. PubMed ID: 10959038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Head injury and the risk of Alzheimer's disease: a case control study.
    Salib E; Hillier V
    Int J Geriatr Psychiatry; 1997 Mar; 12(3):363-8. PubMed ID: 9152722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of dementia in long-term hormone users.
    Petitti DB; Crooks VC; Chiu V; Buckwalter JG; Chui HC
    Am J Epidemiol; 2008 Mar; 167(6):692-700. PubMed ID: 18218608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation between nicotine intake and Alzheimer's disease.
    van Duijn CM; Hofman A
    BMJ; 1991 Jun; 302(6791):1491-4. PubMed ID: 1855016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The number of pregnancies is a risk factor for Alzheimer's disease.
    Colucci M; Cammarata S; Assini A; Croce R; Clerici F; Novello C; Mazzella L; Dagnino N; Mariani C; Tanganelli P
    Eur J Neurol; 2006 Dec; 13(12):1374-7. PubMed ID: 17116223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Onset of dementia is associated with age at menopause in women with Down's syndrome.
    Schupf N; Pang D; Patel BN; Silverman W; Schubert R; Lai F; Kline JK; Stern Y; Ferin M; Tycko B; Mayeux R
    Ann Neurol; 2003 Oct; 54(4):433-8. PubMed ID: 14520653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prior endogenous and exogenous estrogen and incident dementia in the 10th decade of life: The 90+ Study.
    Paganini-Hill A; Corrada MM; Kawas CH
    Climacteric; 2020 Jun; 23(3):311-315. PubMed ID: 32107945
    [No Abstract]   [Full Text] [Related]  

  • 54. The epidemiology of estrogen replacement therapy and Alzheimer's disease.
    Henderson VW
    Neurology; 1997 May; 48(5 Suppl 7):S27-35. PubMed ID: 9153164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection.
    Webber KM; Bowen R; Casadesus G; Perry G; Atwood CS; Smith MA
    Acta Neurobiol Exp (Wars); 2004; 64(1):113-8. PubMed ID: 15190686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lower Death Risk for Vascular Dementia Than for Alzheimer's Disease With Postmenopausal Hormone Therapy Users.
    Mikkola TS; Savolainen-Peltonen H; Tuomikoski P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O
    J Clin Endocrinol Metab; 2017 Mar; 102(3):870-877. PubMed ID: 27906568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of postmenopausal estrogen replacement therapy and the risk of dementia.
    Mortel KF; Meyer JS
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):334-7. PubMed ID: 7580193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.
    Breteler MM; van Duijn CM; Chandra V; Fratiglioni L; Graves AB; Heyman A; Jorm AF; Kokmen E; Kondo K; Mortimer JA
    Int J Epidemiol; 1991; 20 Suppl 2():S36-42. PubMed ID: 1833352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abnormality of gait as a predictor of non-Alzheimer's dementia.
    Verghese J; Lipton RB; Hall CB; Kuslansky G; Katz MJ; Buschke H
    N Engl J Med; 2002 Nov; 347(22):1761-8. PubMed ID: 12456852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.